2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Interventions
pembrolizumab
439
Carboplatin
323
Nivolumab
291
Cyclophosphamide
281
Specimen Handling
271
Magnetic Resonance Spectroscopy
257
Cisplatin
254
Paclitaxel
249
Radiotherapy
229
Gemcitabine
183
Biopsy
182
Dexamethasone
181
durvalumab
169
atezolizumab
151
Rituximab
138
Doxorubicin
135
Lenalidomide
134
Bevacizumab
133
Docetaxel
131
Ipilimumab
129
Capecitabine
120
Radiation
118
Radiosurgery
114
Oxaliplatin
114
Pemetrexed
113
Etoposide
111
Fluorouracil
110
venetoclax
108
fludarabine
106
Prednisone
97
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
UV1 vaccine
×
Clear all
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled